Journal Logo

Secondary Logo

 

January-March 2018 - Volume 32 - Issue 1

  • Dr. José Luchsinger-Stuart, MD, MPH
  • 0893-0341
  • 1546-4156
  • 4 issues / year
  • Clinical Neurology 99/194
    Pathology 27/79
  • 2.395

Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS)

Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H.; More

Alzheimer Disease & Associated Disorders. 32(1):10-17, January-March 2018.

Patient and Caregiver Assessment of the Benefits From the Clinical Use of Amyloid PET Imaging

Mustafa, Rafid; Brosch, Jared R.; Rabinovici, Gil D.; More

Alzheimer Disease & Associated Disorders. 32(1):35-42, January-March 2018.

Baseline White Matter Hyperintensities and Hippocampal Volume are Associated With Conversion From Normal Cognition to Mild Cognitive Impairment in the Framingham Offspring Study

Bangen, Katherine J.; Preis, Sarah R.; Delano-Wood, Lisa; More

Alzheimer Disease & Associated Disorders. 32(1):50-56, January-March 2018.

[18F]-THK5351 PET Imaging in Patients With Semantic Variant Primary Progressive Aphasia

Lee, Hyon; Seo, Seongho; Lee, Sang-Yoon; More

Alzheimer Disease & Associated Disorders. 32(1):62-69, January-March 2018.

Assessing Fitness to Drive in Patients With Different Types of Dementia

Piersma, Dafne; Fuermaier, Anselm B.M.; De Waard, Dick; More

Alzheimer Disease & Associated Disorders. 32(1):70-75, January-March 2018.

Different Exposures to Risk Factors Do Not Explain the Inverse Relationship of Occurrence Between Cancer and Neurodegenerative Diseases: An Italian Nested Case-control Study

Prinelli, Federica; Adorni, Fulvio; Leite, Maria Lea Correa; More

Alzheimer Disease & Associated Disorders. 32(1):76-82, January-March 2018.